Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 1,211 | 0 | 1,282 | 1,028 | 1,081 |
| Cost of Goods | 946 | N/A | 989 | 1,029 | 1,033 |
| Gross Profit | 265 | N/A | 293 | -1 | 48 |
| Operating Expenses | 2,763 | 0 | 2,671 | -1,000 | 1,656 |
| Operating Income | -1,552 | N/A | -1,389 | -1,479 | -1,575 |
| Other Income | 6 | 0 | 29 | 29 | 77 |
| Pre-tax Income | -1,546 | 0 | -1,360 | -1,450 | -1,498 |
| Net Income Continuous | -1,546 | N/A | -1,360 | N/A | -1,498 |
| Net Income | $-1,546 | $N/A | $-1,360 | $N/A | $-1,498 |
| EPS Basic Total Ops | -0.30 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.28 | N/A | -0.25 | N/A | -0.27 |
| EPS Diluted Total Ops | -0.30 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.28 | N/A | -0.25 | N/A | -0.27 |
| EBITDA(a) | $-1,552 | $N/A | $-1,282 | $1,075 | $-1,575 |